Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Diabetologia|April 1, 1983
Control of pulsatile insulin secretion in manD R Matthews, D A Lang, M A Burnett, et al.Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1988
Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetesJ P Hosker, M A Burnett, D R Matthews, et al.Metabolism: Clinical and Experimental|September 1, 1993
Prednisolone enhances beta-cell function independently of ambient glycemic levels in type II diabetesJ P Hosker, M A Burnett, D R Matthews, et al.Diabetes Research (Edinburgh, Scotland)|May 1, 1987
Normal calcium-activated potassium channel in red cells in type 2 diabetesM A Burnett, M Del Vecchio, E Bown, et al.Diabetologia|June 1, 1987
Haemolysis affects insulin but not C-peptide immunoassayS O'Rahilly, M A Burnett, R F Smith, et al.Clinical Endocrinology|July 1, 1985
The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppressionD R Matthews, A S Rudenski, M A Burnett, et al.Diabetologia|November 1, 1985
Sulphonylurea therapy doubles B-cell response to glucose in type 2 diabetic patientsJ P Hosker, M A Burnett, E G Davies, et al.Metabolism: Clinical and Experimental|June 1, 1988
The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion ratesA S Rudenski, J P Hosker, M A Burnett, et al.Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie|March 1, 1983
Serum total hydroxyproline assay: effects of age, sex and Paget's bone diseaseT J Gilbertson, M N Brunden, S B Gruszczyk, et al.Metabolism: Clinical and Experimental|August 1, 1989
Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapyJ P Hosker, A S Rudenski, M A Burnett, et al.Pageof 2